You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 4, 2024

Claims for Patent: 5,776,738

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,776,738

Title:	Method of human prohibitin gene analysis
Abstract:	The 3\' untranslated region of the human prohibitin gene has been isolated for use in a cancer susceptibility screen and as a therapeutic agent for the treatment of cancer.
Inventor(s):	Dell\'Orco, Sr.; Robert Thomas (Edmond, OK), MClung; J. Keith (Norman, OK), Jupe; Eldon (Norman, OK), Liu; Xiao-Tie (Edmond, OK), King; Robert (Oklahoma City, OK)
Assignee:	Oklahoma Medical Research Foundation (Oklahoma City, OK)
Application Number:	08/728,259
Patent Claims:	1. A method of prohibitin gene analysis in a human patient comprising the steps of: a) analyzing the prohibitin genotype of said patient for the occurrence of the prohibitin gene B allele, and; b) analyzing the 3'UTR of the prohibitin gene from said patient for the occurrence of mutations by determining the sequence of the 3'UTR of the prohibitin gene from said patient. 2. The method of claim 1 wherein the prohibitin genotype of said patient is analyzed by polymerase chain reaction (PCR) amplification of a region surrounding the intron 5/exon 6 splice site and single strand conformation polymorphism (SSCP) analysis of the resulting amplified fragment. 3. The method of claim 1 wherein the prohibitin genotype of said patient is analyzed by PCR amplification of a region surrounding the intron 5/exon 6 splice site and digestion of the resulting amplified fragment with BsmAI endonuclease. 4. The method of claim 1 wherein the prohibitin genotype of said patient is analyzed by restriction fragment length polymorphism (RFLP) analysis of the prohibitin gene.

Details for Patent 5,776,738

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986	⤷ Try a Trial	2015-06-07
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132		⤷ Try a Trial	2015-06-07
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132		⤷ Try a Trial	2015-06-07
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.